Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **NOD-like receptor family pyrin domain containing 3 inflammasome** (**NLRP3 inflammasome**) is a multiprotein complex that acts as an intracellular sensor within the innate immune system. It detects diverse danger signals—including pathogen-associated molecular patterns (PAMPs) from microbes and damage-associated molecular patterns (DAMPs) from cellular stress or injury—and responds by assembling into a supramolecular structure. The core components are the sensor protein **NLRP3**, the adaptor protein **ASC** (apoptosis-associated speck-like protein containing a CARD), and the effector enzyme **caspase‑1**. Upon activation, this complex triggers caspase‑1-mediated cleavage of pro-inflammatory cytokines IL‑1β and IL‑18 into their active forms, leading to robust inflammatory responses. It also induces pyroptosis, an inflammatory form of programmed cell death. Activation can be triggered by various stimuli such as extracellular ATP, crystalline substances like monosodium urate crystals, cholesterol crystals, environmental particulates like asbestos or silica dust, microbial toxins, viral RNA/DNA motifs, mitochondrial dysfunction/ROS generation, potassium efflux from cells—and more. Dysregulation or gain-of-function mutations in NLRP3 lead to excessive inflammation implicated in autoinflammatory syndromes such as CAPS; it also plays roles in gout flares via urate crystal sensing; contributes to neurodegeneration through chronic neuroinflammation; is involved in cardiovascular disease via cholesterol crystal sensing; and participates broadly across infectious diseases. Because inappropriate or excessive activity drives pathology across many conditions involving sterile inflammation or infection-induced tissue damage—and because specific inhibitors like MCC950 can block its function—the NLRP3 inflammasome is considered an important therapeutic target for drug development aimed at modulating innate immunity without broadly suppressing host defense mechanisms.[1][2][4][5]
– Direct inhibition of NLRP3 activation or assembly[3] – Blockade of potassium efflux or mitochondrial ROS production to prevent activation[5] – Inhibition of downstream caspase‑1 activity to block cytokine maturation and pyroptosis[1][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOD-like receptor family pyrin domain containing 3 inflammasome (NLRP3 inflammasome).